Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iteos Therapeutics Inc (NQ: ITOS )

15.17 +0.13 (+0.86%)
Streaming Delayed Price Updated: 10:56 AM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Iteos Therapeutics Inc

iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Therapeutics Announces $120 Million Registered Direct Offering
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Participate in Upcoming Investor Conferences
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Participate in Upcoming Investor Conferences
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making... 
Via FinancialNewsMedia
iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at Cowen 43rd Annual Health Care Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at SVB Securities Global Biopharma Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Provides Business Updates and Clinical Development Plans for 2023
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.